3/27/2024 | 38229010 | 1048620 BENAZEPRIL RELATED COMPOUND A (25 MG)(CERTIFIED REFERENCE STANDARDS) | UNITED STATES PHARMACOPEIAL CONVENTION | 2 | NOS | 1619.12 | INDIA | NA |
3/27/2024 | 38229010 | 1048641 BENAZEPRIL RELATED COMPOUND C (50 MG)(CERTIFIED REFERENCE STANDARDS) | UNITED STATES PHARMACOPEIAL CONVENTION | 2 | NOS | 1540.1 | INDIA | NA |
3/19/2024 | 38229010 | 1048641 BENAZEPRIL RELATED COMPOUND C (50 MG)(CERTIFIED REFERENCE STANDARDS) | UNITED STATES PHARMACOPEIAL CONVENTION | 2 | NOS | 1540.1 | INDIA | NA |
3/19/2024 | 38229010 | 1048620 BENAZEPRIL RELATED COMPOUND A (25 MG)(CERTIFIED REFERENCE STANDARDS) | UNITED STATES PHARMACOPEIAL CONVENTION | 2 | NOS | 1619.12 | INDIA | NA |
2/21/2024 | 29337990 | BENAZEPRIL RELATED COMPOUND G (QTY : 1 X 15 MG VALUE USD: 838)(FOC) | USP | 1.5E-05 | KGS | 1027.27 | INDIA | NA |
2/2/2024 | 29337990 | BENAZEPRIL HYDROCHLORIDE (QTY: 2 X 0.2 GMS VALUE: USD 30.36/EACH) (FOC) | UNITED STATES PHARMACOPEIAL CONVENTION | 0.0004 | KGS | 63.94 | INDIA | NA |
2/2/2024 | 29337990 | BENAZEPRIL RELATED COMPOUND E (QTY: 1 X 25 MG VALUE: USD 881) (FOC) | UNITED STATES PHARMACOPEIAL CONVENTION | 2.5E-05 | KGS | 927.76 | INDIA | NA |
2/2/2024 | 29337990 | BENAZEPRIL RELATED COMPOUND A (QTY: 1 X 25 MG VALUE: USD 881) (FOC) | UNITED STATES PHARMACOPEIAL CONVENTION | 2.5E-05 | KGS | 927.76 | INDIA | NA |
2/2/2024 | 29337990 | BENAZEPRIL RELATED COMPOUND F (QTY: 1 X 15 MG VALUE: USD 838) (FOC) | UNITED STATES PHARMACOPEIAL CONVENTION | 1.5E-05 | KGS | 882.48 | INDIA | NA |
2/2/2024 | 29337990 | BENAZEPRIL RELATED COMPOUND C (QTY: 1 X 50 MG VALUE: USD 838) (FOC) | UNITED STATES PHARMACOPEIAL CONVENTION | 5E-05 | KGS | 882.48 | INDIA | NA |